ClinicalTrials.Veeva

Menu

A Study of Pain Relief in Low Back Pain

Abbott logo

Abbott

Status and phase

Completed
Phase 3

Conditions

Chronic Low Back Pain

Treatments

Drug: Extended release hydrocodone and acetaminophen (Vicodin CR)
Drug: hydrocodone/acetaminophen extended release (Vicodin CR)
Drug: placebo

Study type

Interventional

Funder types

Industry

Identifiers

NCT00325949
M05-790

Details and patient eligibility

About

This is a study of the safety and pain-relieving ability of extended release hydrocodone and acetaminophen tablets in patients with moderate to severe low back pain

Enrollment

770 patients

Sex

All

Ages

21 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Males and females, ages 21-75 years
  • If female, must be of non-child bearing potential or practicing birth control
  • Has a history of chronic low back pain for at least 6 months
  • Requires medication for the management of the chronic low back pain
  • Has sufficient pain to justify the use of around-the-clock opioids

Exclusion criteria

  • Is associated with any currently ongoing research study, or has previously participated in a Vicodin CR study
  • Is allergic or has had a serious reaction to hydrocodone, other opioids, or acetaminophen
  • Cannot discontinue pain medications, even for the short time prior to the study start
  • Has any clinically significant illness or recent injury, or has any significant laboratory abnormality, or has recently had major surgery, or plans to have surgery
  • Has a history of gastric bypass surgery or preexisting gastrointestinal narrowing, or history of diseases that may narrow the gastrointestinal tract
  • Has a history of malnutrition or starvation
  • Has a history of drug (licit or illicit) or alcohol abuse or addiction, or consumes more than 4 alcoholic drinks per day
  • Has a history of a major depressive episode within the past 2 years, or requires treatment with certain drugs for depression, or has a history of major psychiatric disorder
  • Is a pregnant or breastfeeding woman
  • Is incapacitated, bedridden, or confined to a wheelchair
  • Has initiated any new therapy or medication for chronic low back pain within 1 month of screening
  • Has had surgery, certain types of low back procedures, injured, or received certain medications for chronic low back pain within a certain specified time frame
  • Has back pain due to or associated with certain types of conditions
  • Has other conditions that may cause pain, such as rheumatoid arthritis, gout, or fibromyalgia

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

770 participants in 3 patient groups, including a placebo group

arm label (1) hydrocodone/acetaminophen extended release
Experimental group
Treatment:
Drug: Extended release hydrocodone and acetaminophen (Vicodin CR)
arm label (2) hydrocodone/acetaminophen extended release
Experimental group
Treatment:
Drug: hydrocodone/acetaminophen extended release (Vicodin CR)
Arm label (3) placebo
Placebo Comparator group
Treatment:
Drug: placebo

Trial contacts and locations

63

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems